Upcoming webinar: Ensuring compliance with animal-free raw materials in CGT

Webinar details Thursday, November 20, 2025 10am EST (NA) / 3pm GMT (UK) / 4pm CET  ·  60 min The production of cell and gene therapies requires strict adherence to regulatory standards that ensure patient safety and product consistency. However, sourcing high-performing, animal-free raw materials that meet these standards remains a major challenge for many […]

Insulin in stem cell culture

Why optimizing insulin supplementation is crucial Stem cells represent one of the most powerful tools in modern biomedical science. Their unique ability to both self-renew and differentiate into specialized cell types makes them invaluable for research, disease modeling, and the development of regenerative therapies. Realizing this potential, however, requires more than the cells themselves—it depends […]

Biosimilar development process

Biosimilar medicines represent an important advancement in healthcare, offering greater patient access to biological therapies that might otherwise be cost-prohibitive. The biosimilar development process revolves around a comprehensive comparability assessment between the proposed biosimilar and its reference biological product. The primary goal of the development process isn’t to establish the efficacy and safety of the […]

Advancing biologics manufacturing 

Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.